This groundbreaking research, originating from the Massachusetts Institute of Technology (MIT), marks a significant stride toward revolutionizing the management of…
Read More
Dulaglutide Shows Promise in Stabilizing Coronary Plaques, Revolutionizing Cardiovascular Protection Beyond Diabetes Management
The intricate relationship between Type 2 diabetes (T2D) and cardiovascular health has long been a focal point of medical research.…
Read More
Novo Nordisk Secures FDA Approval for Awiqli, a Once-Weekly Basal Insulin for Adults with Type 2 Diabetes
The United States Food and Drug Administration (FDA) has granted approval to Novo Nordisk for Awiqli (insulin icodec-abae) injection 700…
Read More
Eli Lilly’s Triple Agonist Retatrutide Achieves Remarkable 16.8% Weight Loss in Phase 3 Trial for Type 2 Diabetes
Eli Lilly and Company has announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Unlocking the Brains Role in Diabetes Management New Study Reveals Metformin Acts Through Hypothalamic Pathways to Regulate Blood Sugar
For more than six decades, metformin has served as the cornerstone of pharmacological intervention for type 2 diabetes, a condition…
Read More
Eli Lilly’s Triple Agonist Achieves 16.8% Weight Loss in Phase 3 Trial for Type 2 Diabetes, Signaling Major Therapeutic Advance
Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
